Samjin Pharmaceutical Co Ltd banner
S

Samjin Pharmaceutical Co Ltd
KRX:005500

Watchlist Manager
Samjin Pharmaceutical Co Ltd
KRX:005500
Watchlist
Price: 18 150 KRW 1.11% Market Closed
Market Cap: ₩227.4B

Profitability Summary

Samjin Pharmaceutical Co Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Samjin Pharmaceutical Co Ltd

Margins Comparison
Samjin Pharmaceutical Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
Samjin Pharmaceutical Co Ltd
KRX:005500
222.5B KRW
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
883.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
585.2B USD
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.5B GBP
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
299.1B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
236.4B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
161B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
120B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Samjin Pharmaceutical Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
Samjin Pharmaceutical Co Ltd
KRX:005500
222.5B KRW
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
883.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
585.2B USD
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.5B GBP
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
299.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
236.4B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
161B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
120B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Samjin Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett